Black Diamond Therapeutics, Inc. (BDTX) NASDAQ

2.11

+0.16(+8.21%)

Updated at May 19 04:00PM

Currency In USD

Valuation

Market Cap117.76M
Enterprise Value103.51M
P/E Ratio21.31
PEG Ratio0.2
Price/Sales Ratio0
Price/Book Ratio0.77
Enterprise/Revenue0
Enterprise/EBITDA-7.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-69.33M
Net Income-69.68M
Diluted EPS-1.27

Balance Sheet

Total Cash98.42M
Total Cash/Share1.74
Total Debt17.88M
Total Debt/Equity0.13
Current Ratio9.24
Book Value Per Share2.5

Price History

52-Week Change-60.71
52-Week High6.75
52-Week Low1.2
Moving Average 50 Days1.62
Moving Average 200 Days2.97

Statistics

Average Volume3.41M
Shares Outstanding56.86M
% Held by Institutions84.78

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A